Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem (Q33870263)

29 July 2017

1 reference

title

Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem (English)

1 reference

29 July 2017

Arroyo V

1

1 reference

PubMed ID

10728802

29 July 2017

Jiménez W

series ordinal

2

1 reference

29 July 2017

1 January 2000

1 reference

29 July 2017

Journal of Hepatology

1 reference

29 July 2017

32

1 reference

29 July 2017

157-170

1 reference

29 July 2017

1 Suppl

1 reference

Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis.

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980423-7

7 January 2021

Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980423-7

7 January 2021

Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980423-7

7 January 2021

Aquaretic agents: a new potential treatment of dilutional hyponatremia in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980423-7

7 January 2021

Spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980423-7

7 January 2021

Pathogenesis of sodium retention in cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980423-7

7 January 2021

The natriuretic peptides and their receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980423-7

7 January 2021

Observations on the sodium-retaining corticoid (aldosterone) in the urine of children and adults in relation to sodium balance and edema

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980423-7

7 January 2021

Increased Sympathetic Nervous Activity and the Effects of Its Inhibition with Clonidine in Alcoholic Cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980423-7

7 January 2021

Atrial natriuretic factor in cirrhosis with ascites: Plasma levels, cardiac release and splanchnic extraction

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980423-7

7 January 2021

Plasma levels of brain natriuretic peptide in patients with cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980423-7

7 January 2021

Urinary excretion of urodilatin in patients with cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980423-7

7 January 2021

Natriuretic hormone activity in the urine of cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980423-7

7 January 2021

Renal and systemic hemodynamics in experimental cirrhosis in rats: relation to hepatic function

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980423-7

7 January 2021

Tubular sodium handling in cirrhotic patients with ascites as analysed by the renal lithium clearance method

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980423-7

7 January 2021

Evidence that renal prostaglandins are involved in renal water metabolism in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980423-7

7 January 2021

Critical differences between species in the in vivo and in vitro renal responses to antidiuretic hormone antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980423-7

7 January 2021

Effect of V1-vasopressin receptor blockade on arterial pressure in conscious rats with cirrhosis and ascites

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980423-7

7 January 2021

Characterization of a novel aquaretic agent, OPC-31260, as an orally effective, nonpeptide vasopressin V2 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980423-7

7 January 2021

Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980423-7

7 January 2021

5-Fluoro-2-methyl-N-[4-(5H-pyrrolo[2,1-c]-[1, 4]benzodiazepin-10(11H)-ylcarbonyl)-3-chlorophenyl]benzamide (VPA-985): an orally active arginine vasopressin antagonist with selectivity for V2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980423-7

7 January 2021

Kappa agonists and vasopressin secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980423-7

7 January 2021

Therapeutic efficacy of the non-peptide AVP antagonist OPC-31260 in cirrhotic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980423-7

7 January 2021

Aquaretic effect of the kappa-opioid agonist RU 51599 in cirrhotic rats with ascites and water retention

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980423-7

7 January 2021

Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980423-7

7 January 2021

Renal effects of natriuretic peptide receptor blockade in cirrhotic rats with ascites.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980423-7

7 January 2021

The hepatorenal syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980423-7

7 January 2021

Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: Relationship with the development of renal impairment and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980423-7

7 January 2021

Nitric oxide production and inducible nitric oxide synthase expression in peritoneal macrophages of cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980423-7

7 January 2021

Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980423-7

7 January 2021

Ornipressin in the treatment of functional renal failure in decompensated liver cirrhosis. Effects on renal hemodynamics and atrial natriuretic factor

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980423-7

7 January 2021

Interrelationship between cardiac output and vascular resistance as determinants of effective arterial blood volume in cirrhotic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980423-7

7 January 2021

Sodium excretion in advanced cirrhosis: effect of expansion of central blood volume and suppression of plasma aldosterone

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980423-7

7 January 2021

Reversal of hepatorenal syndrome in four patients by peroral misoprostol (prostaglandin E1 analogue) and albumin administration

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980423-7

7 January 2021

Oral misoprostol or intravenous prostaglandin E2 do not improve renal function in patients with cirrhosis and ascites with hyponatremia or renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980423-7

7 January 2021

Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980423-7

7 January 2021

Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980423-7

7 January 2021

The enteric nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980423-7

7 January 2021

Fat-storing cells as liver-specific pericytes. Spatial dynamics of agonist-stimulated intracellular calcium transients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980423-7

7 January 2021

Bacterial infections in liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980423-7

7 January 2021

Clinical significance of the evaluation of hepatic reticuloendothelial removal capacity in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980423-7

7 January 2021

Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980423-7

7 January 2021

Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980423-7

7 January 2021

Cost-analysis of prophylactic antibiotics in spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980423-7

7 January 2021

An economic analysis of norfloxacin prophylaxis against spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980423-7

7 January 2021

10.1016/S0168-8278(00)80423-7

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10728802